https://www.avient.com/sites/default/files/2023-08/Avient General Purchase Conditions.pdf
Avient location or
bound for the U.S. as a final destination, Supplier
will provide a TSCA Certificate of Compliance or
a TSCA conformance statement on the SDS.
12.7 If any license or consent of any
government or other authority is required for
the acquisition, carriage or Use of Goods by
Supplier, Supplier will obtain the same at its
expense, and if necessary, provide evidence of
the same to Avient on request.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Slovakia.pdf
Buyer
will sign a reasonable confidentiality agreement upon
request and ensure its employees are bound by at least
equally restrictive confidentiality obligations as those
stated herein.
23.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Arab Emirates.pdf
Buyer will sign a reasonable confidentiality
agreement upon request and ensure its employees are bound by at least
equally restrictive confidentiality obligations as those stated herein.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Pakistan.pdf
Buyer will sign a reasonable confidentiality
agreement upon request and ensure its employees are bound by at
least equally restrictive confidentiality obligations as those stated
herein.
23.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Poland.pdf
Buyer
will sign a reasonable confidentiality agreement upon
request and ensure its employees are bound by at least
equally restrictive confidentiality obligations as those
stated herein.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Denmark.pdf
Buyer will
sign a reasonable confidentiality agreement upon re-
quest and ensure its employees are bound by at least
equally restrictive confidentiality obligations as
those stated herein.
23.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Spain.pdf
Buyer
will sign a reasonable confidentiality agreement upon
request and ensure its employees and service providers are
bound by at least equally restrictive confidentiality
obligations as those stated herein.
23.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Argentina %28English and Spanish Translation%29.pdf
Buyer will
sign a reasonable confidentiality agreement upon request and
ensure its employees are bound by at least equally restrictive
confidentiality obligations as those stated herein.
23.
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
Avient's performance in this environment has been differentiated as a result of our specialty focus, end
market transformation and excellence in execution.
2021 Company performance highlights include:
• Full-year 2021 earnings per share ("EPS") from continuing operations was $2.51, compared to
$1.46 in 2020, an increase of 72%;
• Record sales growth of 27% over 2020 to $4.8 billion;
• Increased adjusted EPS 58% from $1.93 (pro forma for the Clariant Color acquisition) to $3.05(1)
driven by demand for sustainable solutions, healthcare applications and composites
technologies;
• Increased our dividend on an annualized basis by 12% to $0.95; the 11th consecutive year of
annual increase;
• Our 0.55 injury incident rate (per 100 full-time workers per year) is world-class in our industry;
• Certified once again as an ACC Responsible Care® organization for outstanding environmental,
health and safety performance;
• Continued our journey of improving our culture: received our 3rd consecutive certification as a
Great Place to Work® by the Great Place to Work Institute; joined the United Nations Global
Compact; and recognized as one of America's Most Responsible Companies by Newsweek;
• The Specialty Engineered Materials (“SEM”) business delivered record operating income of $132
million, up 40% from 2020, driven by high demand for our composites and other specialty
solutions serving the consumer and healthcare end markets;
• The Color, Additives and Inks ("CAI") business grew revenue 18% and operating income 34%.
Other initiatives, including Mentoring at Avient and campus partnerships are vital for progress in our
diversity and inclusion journey.
COMPENSATION DISCUSSION AND ANALYSIS
44 PROXY STATEMENT 2022 | Annual Meeting of Shareholders
2021 Company performance highlights include:
• Full-year 2021 EPS from continuing operations was $2.51, compared to $1.46 in 2020, an increase
of 72%;
• Record sales growth of 27% over 2020 to $4.8 billion;
• Increased adjusted EPS 58% from $1.93 (pro forma for the Clariant Color acquisition) to $3.05(1)
driven by demand for sustainable solutions, healthcare applications and composites
technologies;
• Increased our dividend on an annualized basis by 12% to $0.95; the 11th consecutive year of
annual increase;
• Our 0.55 injury incident rate (per 100 full-time workers per year) is world-class in our industry;
• Certified once again as an ACC Responsible Care® organization for outstanding environmental,
health and safety performance;
• Continued our journey of improving our culture: received our 3rd consecutive certification as a
Great Place to Work® by the Great Place to Work Institute; joined the United Nations Global
Compact; and recognized as one of America's Most Responsible Companies by Newsweek;
• The SEM business delivered record operating income of $132 million, up 40% from 2020, driven by
high demand for our composites and other specialty solutions serving the consumer and
healthcare end markets;
• The CAI business grew revenue 18% and operating income 34%.
https://www.avient.com/investor-center/news/polyone-announces-full-year-and-fourth-quarter-2018-results
Patterson added, "Overall, I am incredibly pleased with our performance this year when considering that we incurred significantly higher raw material and logistics costs.